Navigation Links
Hospira Announces CEO Succession Plan
Date:8/20/2010

LAKE FOREST, Ill., Aug. 20 /PRNewswire-FirstCall/ -- The board of directors of Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer (CEO), has indicated his intent to retire from the CEO position after more than six years of dedicated service. Begley will serve as CEO until his successor is named. He will then remain an employee of the company as executive chairman of the Hospira board, ensuring continuity of leadership and an orderly transition of his CEO responsibilities.

"Launching Hospira as an independent company has been the most rewarding experience of my three decades in healthcare, and I've been extremely privileged to work with such a talented and dedicated team of employees to advance wellness for our stakeholders around the globe," said Begley. "Over the last six years we have transformed this company from one of declining sales and margins to strong growth and profitability, and the time is right for a new CEO to lead Hospira on its patient-focused journey to sustainable top-tier financial performance. I look forward to remaining an active contributor to Hospira, confident the company is stronger and better positioned for success now than at any point in our rich history."

As the company's founding CEO, Begley oversaw Hospira's 2004 spin-off from Abbott Laboratories, drove the development of the company's business strategies and growth plans, and created the company's guiding principles -- its vision, values and stakeholder commitments. During his tenure, Begley doubled Hospira's geographic footprint and revenue outside the United States, improved adjusted gross margins by more than 1,000 basis points, generated more than $3 billion in cash flow from operations, and doubled its market capitalization.

In 2009, Begley launched Proj
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. Hospira Reports Third-Quarter 2009 Results
7. Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
8. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
9. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
10. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
11. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... December 17, 2014 Revenue and earnings ... on research and development In the past 2013/14 ... by two percent to EUR 4.287 billion (last year: EUR ... 14 percent to EUR 360 million. "Overall, 2013/14 was a ... Michael Kaschke , President and CEO of Carl Zeiss AG. ...
(Date:12/17/2014)... 2014  Beamz Interactive, Inc. (OTCQB: BZIC), a ... announced that it has signed an agreement with ... of innovative prosthetic, orthotic and assistive technology products ... agreement, RSL Steeper will promote and supply the ... use within UK residential care facilities through its ...
(Date:12/17/2014)... , Dec. 17, 2014  RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today announced completion of enrollment in its first Phase ... 3-month observations confirmed the 1-month findings that were ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... work commitment is a big reason why, new research suggests. ... Mathias Basner, an assistant professor of sleep and chronobiology in ... A time-use survey of nearly 125,000 Americans, ages 15 ... exchanged for sleep. Short sleepers -- those who slept six ...
(Date:12/15/2014)... December 15, 2014 South Florida’s leading urgent ... holidays can be a daze of hassle, hustle, and bustle ... while decking halls, to burns when making special meals and ... that can happen at any time. To prevent this season ... has made a list of helpful and healthful holiday tips ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Fostering innovation to speed the improvement of health care ... researchers at Cincinnati Children,s Hospital Medical Center. "The ... broken," says Peter Margolis, MD, PhD, co-Principal Investigator of ... our previous successes, is to create a totally new ...
... , , , ... today that it has changed its corporate name to Ocular Therapeutix, ... more clearly articulates our mission in the ophthalmic marketplace as we ... and develop ocular drug delivery therapies." , , ...
... the psychological distress and burnout experienced by many physicians ... Center researchers report in today,s issue of the ... ). The training also can expand a physician,s ... according to the researchers, who were led by Michael ...
... , Former Vermont Governor to sign new book ... Sept. 23 -- Governor Howard Dean will be in Philadelphia, PA and ... and sign copies of his new book, Howard Dean,s Prescription for Real ... at the Philadelphia Free Library for a noon book signing and discussion. ...
... , , , , ... & Lione, one of the largest intellectual property law firms in the U.S., ... its long-time client Cook Incorporated in a patent infringement case brought by Edwards ... Appeals for the Federal Circuit affirmed the previous ruling of the U.S. District ...
... though, that biggest risk factor is the brain attack itself ... reduce the chances of developing dementia such as Alzheimer,s disease ... concentrating on all the known stroke risk factors, a new ... analysis of 30 previous studies that involved more than 7,500 ...
Cached Medicine News:Health News:Open innovation networks are one key to improved care 2Health News:Open innovation networks are one key to improved care 3Health News:Open innovation networks are one key to improved care 4Health News:Open innovation networks are one key to improved care 5Health News:Mindful meditation, shared dialogues reduce physician burnout 2Health News:Mindful meditation, shared dialogues reduce physician burnout 3Health News:Mindful meditation, shared dialogues reduce physician burnout 4Health News:Brinks Hofer Gilson & Lione Wins Patent Appeal for Cook Incorporated 2Health News:Brinks Hofer Gilson & Lione Wins Patent Appeal for Cook Incorporated 3Health News:Preventing Second Stroke May Stave Off Dementia 2Health News:Preventing Second Stroke May Stave Off Dementia 3
Straight chisel for scoring, cutting, scraping, cleaning and sculpting bone....
Custom-made chisels....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Medicine Products: